Who owns ANEBULO PHARMACEUTICALS INC?
- Ticker: ANEB
- CUSIP Number: 034569103
Tip: Access positions for across all investors
Analyze quarterly positions in Anebulo Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Anebulo Pharmaceuticals stock
Who bought or sold ANEBULO PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| 22NW | 5.4M | $10M | 0% | Sep 2024 |
|
| LVW Advisors | 641k | $1.2M | 0% | Sep 2024 |
|
| Nantahala Capital Management | 511k | $986k | 0% | Sep 2024 |
|
| Morgan Stanley | 399k | $1.1M | 0% | Jun 2024 |
|
| Ikarian Capital | 158k | $305k | 0% | Sep 2024 |
|
| Vanguard Group | 154k | $420k | 0% | Jun 2024 |
|
| Geode Capital Management | 88k | $170k | 71% | Sep 2024 |
|
| BlackRock | 3.9k | $7.5k | 100% | Sep 2024 |
|
| BlackRock | 3.8k | $10k | -7% | Jun 2024 |
|
| Tower Research Capital | 3.3k | $9.0k | -36% | Jun 2024 |
|
| Bank of America Corporation | 76.00 | $146.999200 | 17% | Sep 2024 |
|
| Jpmorgan Chase & Co | 9.00 | $17.000100 | -10% | Sep 2024 |
|
Who sold out of Anebulo Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Royal Bank of Canada | Jun 2024 | 51.00 | $0 |